Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZuraPrep
- Development stage
- Unknown
- Lead developer
- Zurex Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
ZuraPrep is a preoperative skin antiseptic solution developed by Zurex Pharma, Inc. to reduce the risk of surgical site infections (SSIs). Its active ingredient is 70% isopropyl alcohol (IPA), which acts as a broad-spectrum antimicrobial agent by denaturing proteins and dissolving lipid membranes of microorganisms on the skin surface. It is specifically designed for use on the abdomen and inguinal regions prior to surgical procedures. Clinical evaluation has involved Phase 3 trials comparing its efficacy to standard-of-care antiseptics like ChloraPrep (chlorhexidine gluconate/isopropyl alcohol) and vehicle controls.
- Brand names
- ZuraPrep
- Other names
- Zurex Preoperative PrepZuraPrep Clear Solution
Beyond the preview
Go deeper on ZuraPrep.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZuraPrep.